Extended-Release Carvedilol in the Treatment of Hypertension: A Double-Blind, Randomized, Placebo-Controlled Trial
Journal
Acta Cardiologica Sinica
Journal Volume
37
Journal Issue
2
Pages
186
Date Issued
2021-03
Author(s)
Wang, Kang-Ling
Fang, Chih-Yuan
Lai, Wen-Ter
Ueng, Kwo-Chang
Wang, Kuo-Yang
Wang, Ji-Hung
Shyu, Kou-Gi
Chiang, Chern-En
Abstract
Immediate-release carvedilol requires twice-daily dosing and may have low treatment compliance. We assessed the efficacy of a new formulation of once-daily extended-release carvedilol (carvedilol ER) on systolic blood pressure (SBP) and diastolic blood pressure (DBP) among patients with hypertension in this double-blind, randomized, placebo-controlled trial.
Subjects
Carvedilol; Extended-release formulation; Hypertension
SDGs
Publisher
TAIWAN SOC CARDIOLOGY
Type
journal article